Antonello Pileggi

This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: University of Miami, Nogra Pharma Limited, Converge Biotech Inc.. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonello Pileggi. Retrieved from https://idiyas.com/inventor/antonello-pileggi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 60.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 20(Granted Patents)

Location History:

Aventura, FL (US) (2014 - 2018)
Miami, FL (US) (2018 - 2019)

Company Filing History:

Converge Biotech Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10443056 - Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation (2019-10-15),

2. 10081809 - Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation (2018-09-25),

3. 9980923 - Stable liquid formulations of volatile gas anesthetics (2018-05-29),

4. 9308269 - Stable liquid formulations of volatile gas anesthetics (2016-04-12),

5. 8702684 - Therapeutic hybrid implantable devices (2014-04-22),

Title: Antonello Pileggi: Innovator in Diabetes Treatment

Introduction

Antonello Pileggi is a prominent inventor based in Aventura, Florida, known for his significant contributions to the field of diabetes treatment. With a total of five patents to his name, Pileggi has dedicated his career to developing innovative methods that address critical health challenges.

Latest Patents

Among his latest patents, Pileggi has disclosed methods for treating and preventing diabetes through the use of a specific inhibitor of SMAD7 expression or function. These methods also promote the survival of pancreatic islets after transplantation, showcasing his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Antonello Pileggi has worked with esteemed institutions such as the University of Miami and Nogra Pharma Limited. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Camillo D Ricordi and Peter Buchwald, who have played significant roles in his research endeavors.

Conclusion

Antonello Pileggi's innovative work in diabetes treatment and his impressive portfolio of patents highlight his dedication to improving healthcare solutions. His contributions continue to inspire advancements in medical research and patient care.

Profile summary based on public USPTO records.